TRIP is a CBD brand that sells wellness products infused with adaptogens.
TRIP has raised $40.0M in total funding. The most recent round was Undisclosed. The last funding was announced in September 2026.
TRIP's investors include Presight Capital, Coefficient Capital, Melitas Ventures, Maria Frances, Christian Angermayer.
TRIP is headquartered in London, United Kingdom.
TRIP is a CBD brand that sells wellness products infused with adaptogens.
TRIP is at the Undisclosed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"TRIP — Funding & Investors." VCBacked, September 8, 2026, https://www.vcbacked.co/company/trip. Accessed October 19, 2026.
VCBacked. (2026). TRIP — Funding & Investors. Retrieved October 19, 2026, from https://www.vcbacked.co/company/trip
{{cite web |title=TRIP — Funding & Investors |url=https://www.vcbacked.co/company/trip |website=VCBacked |access-date=October 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated